Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer

Journal of Surgical Oncology

Volumn 92, Issue 1, 2005, Pages 17-22

  Barranger, Emmanuel ^a   Dubernard, Gil ^a   Fleurence, José ^a   Antoine, Martine ^a   Darai, Emile ^a   Uzan, Serge ^a  

^a HÔPITAL TENON   (France)

Author keywords

Breast cancer; Morbidity; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARM EDEMA; ARM MUSCLE; ARTICLE; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JOINT MOBILITY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MUSCLE WEAKNESS; PARESTHESIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF EVALUATION; SENTINEL LYMPH NODE; TREATMENT OUTCOME;

ADULT; AGED; ARM; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY;

EID: 26244468770     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20343     Document Type: Article

References (24)

1. Fisher B, Bauer M, Wickerham DL, et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983;52:1551-1557.
2. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
3. Pezner RD, Patterson MP, Hill LR, et al.: Arm lymphedema in patients treated conservatively for breast cancer: Relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 1986;12:2079-2083.
4. Ivens D, Hoe AL, Podd TJ, et al.: Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-138.
5. Warmuth MA, Bowen G, Prosnitz LR, et al.: Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer 1998;83:1362-1368.
6. Tobin MB, Lacey HJ, Meyer L, et al.: The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 1993;72:3248-3252.
7. Ververs JM, Roumen RM, Vingerhoets AJ, et al.: Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-999.
8. Krag DN, Weaver DL, Alex JC, et al.: Surgical resection and radiolocalization ot the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
9. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
10. Leidenius M, Leppanen E, Krogerus L, et al.: Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003;185:127-130.
11. Peintinger F, Reitsamer R, Stranzl H, et al.: Comparison of quality of life and arm complaints after axillary lymph node dissection v.v sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003;89:648-652.
12. Rietman JS, Dijkstra PU, Geertzen JH, et al.: Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2003;98:690-696.
13. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553.
14. Blanchard DK, Donohue JH, Reynolds C, et al.: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-487.
15. Schijven MP, Vingerhoets AJ, Rutten HJ, et al.: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-350.
16. Haid A, Kuehn T, Konstantiniuk P, et al.: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 2002;28:705-710.
17. Haid A, Koberle-Wuhrer R, Knauer M, et al.: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res Treat 2002;73:31-36.
18. Temple LK, Baron R, Cody HS III, et al.: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women. Ann Surg Oncol 2002;9:654-662.
19. Swenson KK, Nissen MJ, Ceronsky C, et al.: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9:745-753.
20. Burak WE, Hollenbeck ST, Zervos EE, et al.: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-27.
21. Schrenk P, Rieger R, Shamiyeh A, et al.: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-614.
22. Goldhirsch A, Wood WC, Gelber RD, et al.: Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003;21:3357-3365.
23. Sprangers MA, Groenvold M, Arraras JF, et al.: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol 1996;14:2756-2768.
24. Fayers P, Bottomley A, EORTC Quality of Life Group; Quality of Life Unit: Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002;38:125-133.